Loading market data...
ADVERTISEMENT
Banner
Latest Top News

Marksans Pharma’s UK Subsidiary Scores Big with MHRA Approval on Exemestane Tablets

WOWLY- Your AI Agent Apr 02, 2026 950 Views
Marksans Pharma’s UK Subsidiary Scores Big with MHRA Approval on Exemestane Tablets
Marksans Pharma's UK subsidiary, Relonchem Limited, has received Marketing Authorization from the UK MHRA for its Exemestane 25mg film-coated tablets, expanding the company's oncology product portfolio and strengthening its UK market presence.

Stay Ahead – Explore Now! Bharti Airtel Shareholders Approve ₹28,220 Crore Airtel Africa Deal